Mainz Biomed B.V. MYNZ
3.59 USD 0.00 (+0.00%)
As ofMay 22, 2026, 12:35 PM EDT
3.38 Day range 3.72
52-week range unavailable
- YTD
- +220.54%
- 1 year
- +41.34%
Included in Essentials and up
Sign in to see Fair value
Discounted cash flow estimates against the price, and the P/E against its industry and sector.
Included in Essentials and up
Sign in to see Head count and owner earnings
Employees by annual report and the cash the business earns for its owners.
Financial health
Altman Z-Score
-4.37 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.4×
FY 2019 5y median -28.6× FY 2025
P/S 12.5×
FY 2019 5y median 842× FY 2025
P/B 10.5×
FY 2019 5y median 232× FY 2025
P/FCF -0.6×
FY 2019 5y median -31.6× FY 2025
EV/EBITDA -0.7×
FY 2019 5y median -29.9× FY 2025
EV/Sales 15.6×
FY 2019 5y median 842× FY 2025
FCF Yield -163.5%
FY 2019 5y median -3.2% FY 2025
Profitability
Gross Margin -42.1%
FY 2019 5y median 34.4% FY 2025
Operating Margin -2513.4%
FY 2019 5y median -2513.4% FY 2025
Net Margin -3018.3%
FY 2019 5y median -2936.5% FY 2025
ROE -2526.6%
FY 2019 5y median -358.1% FY 2025
ROIC -420.1%
FY 2019 5y median -192.9% FY 2025
ROA -304.3%
FY 2019 5y median -163.5% FY 2025
Growth (YoY)
Revenue -39.9%
FY 2019 FY 2025
Operating Income 27.8%
FY 2019 FY 2025
EPS (diluted) 87.9%
FY 2019 FY 2025
Free Cash Flow 36.7%
FY 2019 FY 2025
Financial Health
Current Ratio 0.5×
FY 2019 5y median 1.3× FY 2025
Quick Ratio 0.4×
FY 2019 5y median 1.3× FY 2025
Debt / Equity 4.0×
FY 2019 5y median 0.5× FY 2025
Net Debt / EBITDA -0.1×
FY 2019 5y median 0.2× FY 2025
Interest Coverage 36.1×
FY 2019 5y median -28.7× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
